IS8138A - Gaboxadol for the treatment of depression and other psychiatric disorders - Google Patents

Gaboxadol for the treatment of depression and other psychiatric disorders

Info

Publication number
IS8138A
IS8138A IS8138A IS8138A IS8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A
Authority
IS
Iceland
Prior art keywords
gaboxadol
depression
treatment
psychiatric disorders
psychiatric
Prior art date
Application number
IS8138A
Other languages
Icelandic (is)
Inventor
Sanchez Connie
Ebert Bjarke
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8138(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2004/000459 external-priority patent/WO2004112786A2/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS8138A publication Critical patent/IS8138A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8138A 2003-06-25 2005-11-21 Gaboxadol for the treatment of depression and other psychiatric disorders IS8138A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07
PCT/DK2004/000459 WO2004112786A2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Publications (1)

Publication Number Publication Date
IS8138A true IS8138A (en) 2005-11-21

Family

ID=58707228

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8138A IS8138A (en) 2003-06-25 2005-11-21 Gaboxadol for the treatment of depression and other psychiatric disorders

Country Status (10)

Country Link
KR (1) KR20060025192A (en)
AR (1) AR047550A1 (en)
CA (2) CA2529805A1 (en)
CL (2) CL2004001607A1 (en)
EA (1) EA200600101A1 (en)
IS (1) IS8138A (en)
ME (2) ME00030B (en)
NO (1) NO20060229L (en)
RS (1) RS20050911A (en)
TW (1) TW200509918A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113395962A (en) 2018-11-21 2021-09-14 Certego治疗公司 Gaboxadol for reducing suicidal risk and rapidly relieving depression
CN116267014A (en) 2020-05-20 2023-06-20 Certego治疗公司 Cyclic deuterated gaboxadol and its use for treating psychotic disorders

Also Published As

Publication number Publication date
MEP1908A (en) 2010-02-10
CA2692334A1 (en) 2004-12-29
TW200509918A (en) 2005-03-16
ME00030B (en) 2010-06-10
RS20050911A (en) 2007-08-03
AR047550A1 (en) 2006-01-25
CL2004001607A1 (en) 2005-05-27
CL2010000166A1 (en) 2010-07-02
EA200600101A1 (en) 2006-06-30
NO20060229L (en) 2006-01-16
KR20060025192A (en) 2006-03-20
CA2529805A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
IS8451A (en) Methods and Reagents for the Treatment of Immune Inflammatory Disorders
IS8410A (en) Methods and Reagents for the Treatment of Immune Inflammatory Disorders
DK1644021T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
DK1663978T3 (en) Fluoro-substituted omega-carboxyaryl-diphenylurea for the treatment and prevention of diseases and disorders
IS7977A (en) Combinations and methods of combination therapy
NO20032220D0 (en) Löfteverktöy II and method for using the same
IS8142A (en) Medication useful for the treatment of pain
DK1575597T3 (en) Use of rimexolone for the treatment of eye dryness
DK1660057T3 (en) Combination therapy for the treatment of neovascular eye disorders
DK1474416T3 (en) Dihydrobenzodiazepine-2-one derivatives for the treatment of neurological disorders
DK1641822T3 (en) HETEROLOGICAL IL-17-A / F POLYPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF.
DK1803718T3 (en) 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
IS2722B (en) 1, 2, 3, 4- Tetrasetin indole for the treatment of respiratory diseases
IS8497A (en) Methods and reagents for the treatment of inflammatory diseases
HK1203216A1 (en) Materials and methods for treating disorders of the ear
IS7137A (en) Combination treatment for the treatment of cancer
DK1448205T3 (en) Combinations for the treatment of immuno-inflammatory diseases
NO20045554L (en) Procedure for the treatment of diabetes
NO20055450D0 (en) Combination of an analeptic modafinil and an antidepressant compound for the treatment of depression
NO20052859D0 (en) Process for the preparation of resperidone and its intermediates
NO20052814D0 (en) Cytomodulatory peptides for the treatment of interstitial cystitis
DK1601744T3 (en) ENGINEERING AND PROCEDURE
DK1478438T3 (en) Methods and compositions for the treatment of asthma
DK1589973T4 (en) Formulation and methods for the treatment of thrombocythaemia
DK1727801T3 (en) Piperazines useful for the treatment of pain